PhotoPill Medical is a groundbreaking brand that is revolutionizing the treatment of Inflammatory Bowel Disease (IBD). Harnessing the power of light, PhotoPill Medical has developed a disposable swallowable electronic capsule called the IBD-Cap™. This innovative device utilizes Photo-Bio-Modulation treatment (PBMt) and gut microbiota modulating light protocols to provide personalized and targeted therapy for Crohn's disease.

The FDA has recognized the IBD-Cap™ as a Breakthrough Device for treating non-responsive Crohn's Disease flare-ups. By adapting the treatment to each patient's disease location and individual peristaltic rate, PhotoPill Medical ensures optimal results. This groundbreaking technology offers a safer alternative to existing medications, providing a much-needed and cost-effective solution for intestinal inflammation, mucosal healing, and gut bacteria-related disorders.

Driven by the mission to improve the lives of IBD patients, PhotoPill Medical was founded by Sharon Ben-Yehuda, a biochemist and Crohn's Disease patient herself. With a focus on safety, efficacy, and affordability, the company aims to provide better, more accessible treatments for IBD. Backed by strong intellectual property and an experienced management team, PhotoPill Medical has already demonstrated excellent results in pre-clinical and initial clinical studies.

The company is now embarking on a larger-scale clinical trial and developing the next generation of the IBD-Cap™. In addition to its groundbreaking technology, PhotoPill Medical also embraces the science behind its treatment. Photo-Bio-Modulation treatment (PBMt) uses specific wavelengths of light, mainly Red and Near-Infrared, to effectively address inflammation, wounds, and pain.

This treatment has shown promising results in various mucosal inflammatory conditions, including Crohn's disease and even COVID-19 pneumonia. By targeting both the metabolomic and microbiomic aspects of IBD, PBMt offers a multifaceted approach. It stimulates the mitochondria's activity to increase ATP synthesis, RNA and protein synthesis, and oxygen consumption.

It also influences the gut bacteria population, enhancing epithelial barrier integrity and modulating pro-inflammatory cytokines. With its unique blend of innovative technology and scientific expertise, PhotoPill Medical is dedicated to improving the lives of IBD patients worldwide. By providing safer, cost-effective, and efficacious treatments, the brand is transforming the landscape of IBD care